Physician functioning in pharma industry for 7 years with Pharmacovigilance experience. Reviewing and approving appropriate selection of adverse events (AE) from source documents, assigning appropriate coding for AES, medical history and concomitant medications with MedDRA and WHO-Drug dictionaries. Verifying the determined seriousness of the case Performing or review of ICSR case assessment including listedness/ expectedness, of the Adverse events with Reference Safety Information (IB, CCDS, SmPC, USPI) Oversight of medical review cases done by vendor and providing inputs on assessment and medical evaluation comment Providing medical safety input, and reviewing or drafting sections of response documents to health authority inquiries, as appropriate. Identifying, reviewing and un-blinding (If applicable) SUSAR cases Reviewed aggregate safety data to provide medical input into aggregate safety reports such as PBRER, DSUR, PSUR, PADER. Experience in Signal management activities with expertise in authoring signal evaluation reports and recommending next steps of action to senior management. Experience in review of clinical trial protocol, CRFs, Investigator’s brochures, Informed consent forms and CSR Maintaining an excellent knowledge profile of assigned drugs, Reviewing and updating RSI documents on safety database Liaise with Medical Monitor for co-ordination and reconciliation of Immediately Reportable Events (IREs) between site and Safety Team. Supported global clinical development, medical affairs, data sciences and regulatory activities as the pharmacovigilance representative. Proficient in Safety databases such as ARGUS, ARISg, Rave, Rave-X, Jarvis, Veeva Vault, CDOD, Empirica, etc High level of understanding of applicable regulations, including FDA (21CFR 312 and 314), ICH (E2A, E2B, E2C), GCP guidelines, EMA regulations, GVP Modules, etc. Mentoring and training new staff as required for overall understanding and compliance of the company.
Dedicated healthcare professional with strong foundation in pharmacovigilance and patient safety. Proven ability to assess and mitigate drug-related risks, ensuring compliance with regulatory standards. Known for fostering team collaboration and delivering reliable outcomes in dynamic settings.